Trillium Therapeutics Inc (TRIL.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2019 | 12-2018 | 09-2018 | 06-2018 | 03-2018 | |
| Operating Expenses | 8,187 | 6,502 | 9,173 | 10,621 | 8,030 |
| Operating Income | -8,187 | -6,502 | -9,173 | -10,621 | -8,030 |
| Interest Expense | 38 | 6 | 8 | 8 | 9 |
| Other Income | 229 | 1,579 | -920 | 1,268 | 1,409 |
| Pre-tax Income | -7,996 | -4,929 | -10,101 | -9,361 | -6,631 |
| Income Tax | 2 | 0 | 1 | 3 | 2 |
| Net Income Continuous | -7,998 | -4,929 | -10,102 | -9,364 | -6,632 |
| Net Income | $-7,998 | $-4,929 | $-10,102 | $-9,364 | $-6,632 |
| EPS Basic Total Ops | -0.46 | -0.32 | -0.70 | -0.70 | -0.50 |
| EPS Basic Continuous Ops | -0.46 | -0.32 | -0.70 | -0.70 | -0.50 |
| EPS Diluted Total Ops | -0.46 | -0.32 | -0.70 | -0.70 | -0.50 |
| EPS Diluted Continuous Ops | -0.46 | -0.32 | -0.70 | -0.70 | -0.50 |
| EBITDA(a) | $-7,349 | $-4,440 | $-9,463 | $-8,766 | $-6,012 |